Top Biotech Companies (3,709)
RxResults is a pharmacy benefits risk management company developing a suite of clinical tools to reduce cost.
At Epoch, we use advanced biodesign to develop natural solutions to unnatural problems. We have started by designing and scaling the first enzymes capable of transforming plastics into low-carbon, circular chemicals.
Feldan is a biopharmaceutical company that specializes in the development of treatments based on the intracellular delivery of therapeutics. Feldan designed a proprietary, peptide-based technology that enables safe and efficient delivery of various compounds inside cells. The Shuttle technology unlocks the development of a new generation of therapies by giving access to intracellular components beyond the reach of existing drugs....
At DaltonTx, we are redefining how technology powers drug discovery — creating the intelligence engine behind tomorrow’s medicines. Our adaptive, AI-enabled platforms give pharma, biotech, and CROs the intelligence backbone modern R&D cannot move forward without. Purpose-built for small molecules and biologics, our technology integrates seamlessly into scientific workflows, learns from every experiment, and accelerates the path from idea to medicine. Unlike...
Senescent cells, which are characterized by irreversible damage and an inflammatory secretome, are considered a key driving force behind many age-related diseases. Due to a failure in immune surveillance, senescent cells accumulate and impact their local environment by inducing inflammation and promoting extracellular matrix remodeling, thus resulting in a myriad of metabolic and fibrotic consequences. Therefore, enabling the removal of...
Cell-based drug and biologics delivery platform technology company focused on immune-oncology and inflammatory diseases.
Evestra, Inc., a pharmaceutical company, develops and commercializes short-and long-term products in the female health care therapeutic
PERSOWN’s mission is to make accurate, low-cost point-of-care diagnostic testing and secure patient data available instantly to everyone across the globe, including those in resource-limited or logistically remote areas, in order to improve and save lives. Our vision is a world in which no one suffers or dies from communicable disease, everyone receives swift, effective care when unavoidable illness arises, and...
Founded in 1998 to support HIV vaccine research, ProSci has utilized its infectious disease expertise to develop exceptional, high-quality antibodies, recombinant proteins, and other reagents for a vast number of research areas. As one of the first companies to market COVID-19 products, ProSci holds a broad catalog of SARS-CoV-2 reagents and is continuously expanding our portfolio. ProSci also specializes in custom...
GPB Scientific is a biotechnology company that markets its technology to life sciences companies and research establishments.
Best Practices provides consulting and advisory services to Pharma, Biotech, Medical Device and other Healthcare companies. We believe that patients and their families deserve great medical outcomes and it is our mission to help healthcare companies in making that possible by providing answers to the simple question: How do other companies do it? "It" can be any strategic issue or need...
At Amphista Therapeutics we are developing drugs to bring life-changing medicines to patients. Powered by transformational science we are advancing beyond traditional degrader approaches, addressing limitations associated with the use of a narrow range of protein degrading mechanisms. Amphista Therapeutics is an exciting spin out company founded by Advent Life Sciences and built on groundbreaking science from the laboratory of Professor...
Dmed is a manufacturer of cutting-edge biomedical devices that has been continuously researching and developing new materials based on biomaterials and biocompatible materials.
At KBP we are consistently reminded that patient care is the end goal of what we do daily. Our discovery team is highly experienced in identifying new compounds with potential. The close interactions of the discovery and development teams result in a deep pipeline with multiple clinical and pre-clinical compounds. The major organ research group is focused on the maintenance and postponement...
TGen, an affiliate of City of Hope, is a non-profit 501(c)(3) organization focused on developing earlier diagnostics and smarter treatments. Translational genomics research is a relatively new field employing innovative advances arising from the Human Genome Project and applying them to the development of diagnostics and treatments for cancer, neurological disorders, rare childhood disorders, infectious disease and other complex conditions. Stay up-to-date:...
Zucara Therapeutics, a CDRD and MaRS Innovation portfolio company, is developing the first drug therapy to prevent hypoglycemia in people with diabetes. Our first-in-class therapeutic is focused on improving glucagon counterregulation by inhibiting somatostatin which is dysregulated in Type 1 diabetes. Preventing hypoglycemia will dramatically change diabetes disease management, improving both patient health and quality of life.
Sujana Biotech develops novel therapeutics for inflammatory and vascular disorders.
Entoura is building an institutional scale & high quality and supply chain solution for Hemp, CBD Oil and Isolates. We have developed a multidisciplinary approach, bringing the best of genetic research, innovative farm practices, whole plant processing techniques, and manufacturing to produce the highest quality hemp derived cannabinoid products in a controlled supply chain environment, ensuring every stage, from seed...
Anatomi is advancing the fundamental understanding of neurodevelopment and genuine human neural networks.
Capricor Therapeutics is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of cell and exosome-based therapeutics. Its lead product candidate, Deramiocel, is an allogeneic cell therapy currently in late-stage clinical development for the treatment of Duchenne muscular dystrophy (DMD). The company also leverages its proprietary StealthX™ exosome platform for the targeted delivery of therapeutic agents to treat...
